Home > Healthcare > Medical Devices > Diagnostic Devices > Blood Culture Tests Market

Blood Culture Tests Market Share

Report ID: GMI7701
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Blood Culture Tests Market Share

The blood culture tests industry is consolidated, with key players including Becton, Dickinson and Company, Terumo Corporation, BioMerieux SA, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in April 2022, BioMerieux SA entered into agreement with the U.S. based privately held Specific Diagnostics company that offers rapid antimicrobial susceptibility test (AST) system, delivering phenotypic AST directly from positive blood cultures. This agreement helped the company to enhance its market position.

Blood Culture Tests Market Companies

Some of the eminent market participants operating in the blood culture tests industry include:

Becton, Dickinson and Company
Terumo Corporation
bioMerieux SA
Bruker Corporation
T2 Biosystems Inc.
Abbott Laboratories
Luminex Corporation
Siemens Healthineers AG
F. Hoffmann-La Roche AG
Danaher Corporation
Neogen Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of blood culture tests was worth USD 5.8 billion in 2022 and is estimated to reach USD 11.5 billion by 2032 as these tests are crucial in identifying and diagnosing bloodstream infections, which can be serious and life-threatening if not promptly treated.

The consumables segment garnered USD 3.5 billion in 2023 and will grow significantly through 2032, due to an increased emphasis on the quality of culture media.

U.S. blood culture tests market accounted for USD 2.2 billion in 2023 and is predicted to witness substantial growth through 2032, owing to the increasing healthcare investments, a rising burden of infectious and chronic diseases, and efforts to expand healthcare access.

Becton, Dickinson and Company, Terumo Corporation, bioMerieux SA, Bruker Corporation, T2 Biosystems Inc., Abbott Laboratories, Luminex Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Neogen Corporation, and Thermo Fisher Scientific Inc.